$2.32
-0.12-4.92%
Last update: Oct 26, 7:09 AM
CytomX Therapeutics Inc
CTMXNASDAQ
CytomX Therapeutics (CTMX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.10 | $-0.12 | $-0.09 | $-0.04 |
| Actual | $-0.09 | $-0.10 | $-0.22 | $-0.09 |
| Surprise | +10.0% | +16.7% | -144.4% | -125.0% |
| Revenue | ||||
| Estimate | $11.3M | $4.4M | $7.3M | $12.0M |
| Actual | $1.4M | $10.3M | $663000 | $6.0M |
| Surprise | -87.5% | +130.8% | -91.0% | -50.4% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.07 | $-0.10 | $-0.11 | $-0.12 |
| Revenue | ||||
| Consensus | $9.2M | $5.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.09 | $-0.10 | 10.0 % |
| Q1 | May 7, 2026 | $-0.10 | $-0.12 | 16.7 % |
| Q4 | Mar 16, 2026 | $-0.22 | $-0.09 | -144.4 % |
| Q3 | Nov 6, 2025 | $-0.09 | $-0.04 | -125.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $1.42M | $11.31M | -87.5 % |
| Q1 | May 7, 2026 | $10.26M | $4.44M | 130.8 % |
| Q4 | Mar 16, 2026 | $663.00K | $7.34M | -91.0 % |
| Q3 | Nov 6, 2025 | $5.96M | $12.02M | -50.4 % |
